Back to
MILLENNIUM MANAGEMENT LLC
IKT6 quarters
Position history for
MILLENNIUM MANAGEMENT LLC's holdings in INHIBIKASE THERAPEUTICS INC
Yes. Millennium Management holds 4,028,102 shares of IKT (Inhibikase Therapeutics), worth $8.2M, as of its Q2 2026 13F filing. It increased the position by 1,100,025 shares (+37.6%) from Q1 2026. Millennium Management has held IKT since Q4 2025, across 3 quarterly 13F filings.
Current Value
$8.2M
Current Shares
4M
Total Value Change
+$7.7M
Total Shares Change
+3.9M
Quarter-by-Quarter History
Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC